Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myeloma.

Autor: Nedal TMV; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Moen SH; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Research, Nord-Trøndelag Hospital Trust, Levanger, Norway., Roseth IA; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Tryggestad SS; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Aass KR; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Hov GG; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Clinical Chemistry, St. Olavs Hospital, Trondheim, Norway., Hella H; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Sponaas AM; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Standal T; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. therese.standal@ntnu.no.; Department of Hematology, St. Olavs Hospital, Trondheim, Norway. therese.standal@ntnu.no.

Publikováno v: Scientific reports [Sci Rep] 2024 Feb 13; Vol. 14 (1), pp. 3643. Date of Electronic Publication: 2024 Feb 13.

Reference change values of FIB-4.

Autor: Åsberg A; Department of Clinical Chemistry, St. Olav's Hospital, Trondheim, Norway., Løfblad L; Department of Clinical Chemistry, St. Olav's Hospital, Trondheim, Norway., Hov GG; Department of Clinical Chemistry, St. Olav's Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Mikkelsen G; Department of Clinical Chemistry, St. Olav's Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.

Publikováno v: Scandinavian journal of clinical and laboratory investigation [Scand J Clin Lab Invest] 2023 Oct; Vol. 83 (6), pp. 394-396. Date of Electronic Publication: 2023 Jul 28.

The likelihood ratios of FIB-4-values for diagnosing advanced liver fibrosis in patients with NAFLD.

Autor: Åsberg A; Department of Clinical Chemistry, St. Olav's Hospital, Trondheim, Norway., Løfblad L; Department of Clinical Chemistry, St. Olav's Hospital, Trondheim, Norway., Hov GG; Department of Clinical Chemistry, St. Olav's Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.

Publikováno v: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2023 Jun 01; Vol. 61 (11), pp. e233-e234. Date of Electronic Publication: 2023 Jun 01 (Print Publication: 2023).

Inflammatory markers and risk of cardiovascular mortality in relation to diabetes status in the HUNT study.

Autor: Løfblad L; Department of Clinical Chemistry, St. Olavs University Hospital, Trondheim, Norway. lena.lofblad@stolav.no., Hov GG; Department of Clinical Chemistry, St. Olavs University Hospital, Trondheim, Norway.; Department of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway., Åsberg A; Department of Clinical Chemistry, St. Olavs University Hospital, Trondheim, Norway., Videm V; Department of Clinical and Molecular Medicine, NTNU-Norwegian University of Science and Technology, Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olavs University Hospital, Trondheim, Norway.

Publikováno v: Scientific reports [Sci Rep] 2021 Aug 02; Vol. 11 (1), pp. 15644. Date of Electronic Publication: 2021 Aug 02.

Diagnosing empty iron stores in women: unbound iron binding capacity (UIBC) versus soluble transferrin receptor (sTFR).

Autor: Åsberg A; Department of Clinical Chemistry, Trondheim University Hospital, Trondheim, Norway., Thorstensen K; Department of Clinical Chemistry, Trondheim University Hospital, Trondheim, Norway., Hov GG; Department of Clinical Chemistry, Trondheim University Hospital, Trondheim, Norway., Åsberg AE; Department of Pediatrics, Trondheim University Hospital, Trondheim, Norway.

Publikováno v: Scandinavian journal of clinical and laboratory investigation [Scand J Clin Lab Invest] 2021 Apr; Vol. 81 (2), pp. 137-141. Date of Electronic Publication: 2021 Jan 19.